Abstract: Tuberculosis (TB) is a growing problem worldwide, with an estimated third of the world's population currently infected. Of particular concern is the growing trend of dual epidemics of HIV and TB, with the associated multidrug-resistant TB (MDR-TB). Developed countries which had previously removed TB transmission from communities are being re-infected with the MDR-TB strains. In the USA, Centers for Disease Control & Prevention (2009) estimate that treatment of a single case of MDR-TB costs approximately USD$250,000, with a similar cost expected in Australia.
INTRODUCTION
Tuberculosis (TB) is a growing problem worldwide, especially with the emergence and high prevalence of multidrug-resistant strains. A third of the world population is estimated to be infected with TB, and the highest ever rates of multidrug-resistant TB were reported in 2010 [World Health Organisation 2010] .
There has been some recent modelling work on TB transmission dynamics. Basu and Galvani (2008) and Rodrigues et al. (2007) have used models to consider drug-resistant TB, and Sharomi et al. (2008) and Roeger et al. (2009) have considered co-epidemics of HIV and TB. Baltussen et al. (2005) , and Currie et al. (2005) , consider both co-epidemics of HIV and TB, and drug-resistance through a failed treatment group, but do not explicitly consider a drug-resistant TB strain. Basu et al. (2009) also consider both co-epidemics of HIV and TB and drug-resistance, but their model focuses on a HIV intervention in Botswana. Thomas et al. (2010) consider the spread of TB in the Torres Strait region. Although they included both HIV and MDR-TB in their 'detailed' model, they do not include compartments to analyse intervention strategies. Therefore, a significant difference of this work is the inclusion of compartments to explicitly model interventions, such as the WHO recommended DOTS program. In particular, we perform a sensitivity analysis of the model to determine the most influential parameters. This is important in terms of both data collection and refinement, and in the context of control of TB.
THE MODEL
Here we construct a relatively simple model for drug sensitive TB that ignores multidrug-resistant TB (MDR-TB) and HIV. Although these are important factors for TB, an understanding of the dynamics of TB is more straightforward with a simpler model. Future work will extend this model to include MDR-TB and then HIV to determine their importance by comparing the results to the baseline model presented in this article. The model is a population level compartment model, where the population is divided into discrete compartments each representing a different stage of the disease. TB is a many-faceted disease, and hence the model is reasonably detailed to capture this complexity. Figure 1 depicts the compartment model for drug sensitive TB, based on previous work by Blower et al. (1995) and Thomas et al. (2010) , though suitably altered to include aspects relevant to the explored DOTS (Directly Observed Treatment Short-course) intervention. The parameter descriptions and assumptions are presented in Table 1 , Appendix A.
The population is divided into 6 compartments, 4 pertain to the disease (S, L, I, P ), and 2 for the intervention (D & T ). The 4 compartments for disease can be divided into three main groups:
1. those susceptible to TB (S), 2. those latently infected with TB (L), and 3. those with clinically active TB, namely extra-pulmonary (P) and the infectious pulmonary (I).
There are two different paths to having the clinically active disease: a proportion of recently infected individuals develop fast TB, whereas the rest, 1 − , have the slow latent infection. Note that is a probability, and not a rate. It is assumed that once someone is latently infected, they remain so until either death or they become clinically active. Progression from latent to active infection occurs with rate ν. Those with active TB are further divided into two groups. The proportion ρ are able to infect others, and have pulmonary infections (I); and the remainder, 1 − ρ, are not able to infect others, and have extrapulmonary infections (P). Once clinically active, it is possible for someone to spontaneously clear TB from their system, with rate ω. Those with clinically active TB have a higher death rate, µ T , than the natural death rate of the susceptible and latently infected, µ N .
The remaining population compartments are for the DOTS intervention program. The relevant DOTS treatment outcomes, as specified by the WHO (2009), are:
• cured (with probability c I ) -former patients from compartment 'I' who are no longer infectious.
• completed treatment (with rate ζ) -patients from compartment 'P' who have completed treatment.
• defaulted (with rate ψ) -patients with interrupted treatment for two consecutive months or more. Table 1 and the text.
The rate of progression from the clinically active but non-infectious (P) back to the susceptible compartment (S) is a combination of 'completed treatment' and the natural cure rate: c P = (ω + δξζ), where δ and ξ are described below. The most important group for the transmission dynamics are those with pulmonary TB who are able to infect others. Therefore, compartment (I) progresses to compartments which describe the DOTS intervention program; compartments for those who have been detected (D), and those who are undergoing treatment but are still infectious (T). The detection rate, δ(t), is a time dependent function, staying at zero until the DOTS program begins in 1997 and increasing to the current value,
It is assumed that everyone detected is treated, after a delay of 1/θ, unless they die first. It is also assumed that once someone defaults from treatment they are no longer 'detected'. That is, they return to the 'I' compartment. This follows from the assumption that all detected are treated, and that those undergoing treatment have either success or failure. Those who have failed treatment implicitly return to the treatment compartment (T) with rate ξ(1 − c I ), where 1/ξ is the duration a person is infectious whilst undergoing treatment. Comparatively short average durations are expected for the populations in either the detection or treatment compartments (D & T), hence a natural cure rate was not included.
The governing system of equations is hence given bẏ
where the over-dot denotes the derivative with respect to time, b is the birth rate of susceptibles into the population, N = (S + L + I + P + D + T ) is the total population, the force of infection λ = β(I + D + T )/N , and β is the transmission rate when a susceptible meets an infectious individual. Note the transmission rate is assumed to be equal for compartments I, D, & T, which is why 'T' is defined as those undergoing treatment who are still infectious. A full list of parameters and their definitions is given in The transmission rate, β, was then chosen such that the incidence, prevalence, and death rate outputs matched the available data for PNG from the WHO (2009), as well as the total population in 2000. Other parameters were informed by the literature and the disease aetiology, as outlined in Table 1 . The initial conditions for the sensitivity analysis were subsequently determined by the output of the '1800' run in the year equivalent to 1990. The sensitivity analysis was run from 1990 to 2032, as this allows the model to settle and covers the period of interest .
SENSITIVITY ANALYSIS
Essential to any mathematical model of disease progression is a sensitivity analysis to ascertain which parameters dominate the results. Latin Hypercube Sampling is used to efficiently cover the parameter space, in conjunction with Partial Rank Correlation Coefficient (PRCC) multivariate analysis to determine the dominant parameters, as previously done by Sanchez and Blower (1997) , Marino et al. (2008) , inter alios. A PRCC rank close to magnitude 1 indicates a dominant parameter, while the least important parameter rank coefficients are near zero. The PRCC analysis requires a monotonically increasing function, hence the cumulative number with clinically active TB (P + I + D + T ) is used.
The parameter values are used from the PNG case study, though several are excluded from the sensitivity analysis as they are not of interest for our study: the birth rate, b; the natural death rate, µ N . The total population, N , was also excluded. Hence there are 12 parameters of interest (noting c P is calculated using other parameters). In keeping with previous work [Thomas et al. 2010] and others, triangular distributions are assumed for all parameters, with a range of ±50% the value presented in Table 1 , Appendix A. To explore the stability of the results to the width of the distribution, ranges from ±10% to ±90% were also explored, and the results were qualitatively the same, with relatively small quantitative differences in the rank. 2000 samples were generated using the Latin Hypercube. Figure 2 depicts the result of the sensitivity analysis, where parameters with low sensitivity, PRCC value ≤ |0.1|, have been excluded. The latent period for TB is long (20 years on average), and so the number of individuals in the 'L' compartment accumulates and provides a large reservoir for new active cases. As a result, the rate those latently infected become clinically active, ν, is of more importance to the TB dynamics than the transmission rate, β. Therefore, data refinement should concentrate on determining the rate ν as accurately as possible. The latently infected reservoir also explains why the proportion with fast TB, , becomes less important as the epidemic progresses. The inclusion of the disease parameters ω and ρ is understandable, as the number of people and period of time the clinically active and infectious are able to infect others are obviously important factors. The only intervention parameter with a magnitude > 0.1 is the detection rate, δ(t). Within the intervention parameters, the rate of detection being the most important makes sense, as we assume all those detected are treated. 
CONCLUSIONS
The sensitivity analysis shows that 5 of the 6 most important parameters pertain to the disease itself, and these are not easily influenced by interventions. However amongst the intervention parameters, the detection rate, δ, has a reasonably important influence on the cumulative number of people with clinically active TB. In PNG, the current DOTS detection rate is at a mere 14%. The more remote regions, such as in the Western Province, are likely to have an even lower detection rate. Increasing δ(t) to the WHO target of 70% case detection may not be viable given the small, isolated communities in the regional areas of PNG, but the sensitivity analysis suggests that increases smaller than the target will still have a significant impact in reducing (negative correlation) both the incidence and prevalence of TB.
The model presented here is a relatively simple population level compartment model. Future work will extend this to include a metapopulation, to explore the cross-border transmission dynamics of TB in the PNG-Torres Strait Island region. Further extensions will consider multidrug-resistant TB and the coepidemic of HIV, to determine the simplest possible realistic model of TB for transmission from high to low burden regions. 
